Tetramer-guided analysis of TCR β-chain usage reveals a large repertoire of Melan-A-specific CD8+ T cells in melanoma patients

Journal of Immunology

Volumn 165, Issue 1, 2000, Pages 533-538

  Valmori, Danila ^a,e   Dutoit, Valérie ^a   Liénard, Danielle ^a   Lejeune, Ferdy ^a   Speiser, Daniel ^a   Rimoldi, Donata ^b   Cerundolo, Vincenzo ^c   Dietrich, Pierre Yves ^d   Cerottini, Jean Charles ^a   Romero, Pedro ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL   (Switzerland)

^e Hopital Orthopedique de la Suisse Romande   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR BETA CHAIN;

ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MELANOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; TUMOR IMMUNOLOGY;

EID: 0034234615     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.1.533     Document Type: Article

References (29)

1. Clemente, C. G., M. C. Mihm, Jr., R. Bufalino, S. Zurrida, P. Collini, and N. Cascinelli. 1996. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77:1303.
2. Mihm, M. C., Jr., C. G. Clemente, and N. Cascinelli. 1996. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab. Invest. 74:43.
3. Clark, W. H., Jr., D. E. Elder, D. Guerry, L. E. Braitman, B. J. Trock, D. Schultz, M. Synnestvedt, and A. C. Halpern. 1989. Model predicting survival in stage I melanoma based on tumor progression. J. Natl. Cancer Inst. 81:1893.
4. Ferradini, L., S. Roman-Roman, J. Azocar, M. F. Avril, S. Viel, F. Triebel, and T. Hercend. 1992. Analysis of T-cell receptor a/b variability in lymphocytes infiltrating a melanoma metastasis. Cancer Res. 52:4649.
5. Ferradini, L., A. Mackensen, C. Genevée, J. Bosq, P. Duvillard, M. F. Avril, and T. Hercend. 1993. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. J. Clin. Invest. 91:1183.
6. Shilyansky, J., M. I. Nishimura, J. R. Yannelli, Y. Kawakami, L. S. Jacknin, P. Charmley, and S. A. Rosenberg. 1994. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. Proc. Natl. Acad. Sci. USA 91:2829.
7. Sensi, M., S. Salvi, C. Castelli, C. Maccalli, A. Mazzocchi, R. Mortarini, G. Nicolini, M. Herlyn, G. Parmiani, and A. Anichini. 1993. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR β chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. J. Exp. Med. 178:1231.
8. Cole, D. J., D. P. Weil, P. Shamamian, L. Rivoltini, Y. Kawakami, S. Topalian, C. Jennings, S. Eliyahu, S. A. Rosenberg, and M. I. Nishimura. 1994. Identification of MART-1 -specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope. Cancer Res. 54:5265.
9. Cole, D. J., M. C. Wilson, L. Rivoltini, M. Custer, and M. I. Nishimura. 1997. T-cell receptor repertoire in matched peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Cancer Res. 57:5320.
10. Romero, P., C. Pannetier, J. Herman, C. V. Jongeneel, J.-C. Cerottini, and P. Coulie. 1995. Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1. Al. J. Exp. Med. 182:1019.
11. Romero, P., N. Gervois, J. Schneider, P. Escobar, D. Valmori, C. Pannetier, A. Steinle, T. Wölfel, D. Liénard, V. Brichard, et al. 1997. Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma. J. Immunol. 159:2366.
12. Romero, P., P. R. Dunbar, D. Valmori, M. J. Pittet, G. S. Ogg, D. Rimoldi, J. L. Chen, D. Liénard, J.-C. Cerottini, and V. Cerundolo. 1998. Ex vivo staining of metastatic lymph nodes by class 1 major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188:1641.
13. + T cells in a large proportion of HLA-A2 individuals. J. Exp. Med. 190:705.
14. Valmori, D., M. J. Pittet, D. Rimoldi, D. Liénard, R. Dunbar, V. Cerundolo, F. Lejeune, J.-C. Cerottini, and P. Romero. 1999. An antigen targeted approach to adoptive transfer therapy of cancer. Cancer Res. 59:2167.
15. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
16. Valmori, D., N. Gervois, D. Rimoldi, J. F. Fonteneau, A. Bonelo, D. Liénard, L. Rivoltini, F. Jotereau, J.-C. Cerottini, and P. Romero. 1998. Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide. J. Immunol. 161:6956.
17. Kawakami, Y., S. Eliyahu, C. H. Delgado, P. F. Robbins, L. Rivoltini, S. L. Topalian, T. Miki, and S. A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Prof. Natl. Acad. Sci. USA 91:3515.
18. + T cells with enhanced functional characteristics: implication for more effective immunotherapy. Cancer Res. 59:301.
19. Moss, P. A. H., R. J. Moots, W. M. C. Rosenberg, S. J. Rowland-Jones, H. C. Bodmer, A. J. McMichael, and J. I. Bell. 1991. Extensive conservation of α and β chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc. Natl. Acad. Sci. USA 88:8987.
20. Lehner, P. J.. E. C. Y. Wang, P. A. H. Moss, S. Williams, K. Platt, S. M. Friedman, J. I. Bell, and L. K. Borysiewicz. 1995. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the Vb17 gene segment. J. Exp. Med. 181:79.
21. Bowness, P., P. A. H. Moss, S. Rowland-Jones, J. I. Bell, and A. J. McMichael. 1993. Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses. Eur. J. Immunol. 23:1417.
22. Argaet, V. P., C. W. Schmidt, S. R. Burrows, S. L. Silins, M. G. Kurilla, D. L. Doolan, A. Suhrbier, D. J. Moss, E. Kieff, T. B. Sculley, et al. 1994. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J. Exp. Med. 180:2335.
23. Genevee, C., A. Diu, J. Nierat, A. Caignard, P. Y. Dietrich, L. Ferradini, S. Roman-Roman, F. Triebel, and T. Hercend. 1992. An experimentally validated panel of subfamily-specific oligonucleotide primers (Vα1-w29/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur. J. Immunol. 22:1261.
24. Nishimura, M. I., Y. Kawakami, P. Charmley, B. O'Neil, J. Shilyansky, J. R. Yannelli, S. A. Rosenberg, and L. Hood. 1994. T-cell receptor repertoire in tumor-infiltrating lymphocytes: analysis of melanoma-specific long-term lines. J. Immunother. 16:85.
25. Puisieux, I., J. Even, C. Pannetier, F. Jotereau, M. Favrot, and P. Kourilsky. 1994. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J. Immunol. 153:2807.
26. Pannetier, C., J. Even, and P. Kourilsky. 1995. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today 16:176.
27. Casanova, J. L., and J. L. Maryanski. 1993. Antigen-selected T-cell receptor diversity and self-nonself homology. Immunol. Today 14:391.
28. Kalams, S. A., R. P. Johnson, A. K. Trocha, M. J. Dynan, H. S. Ngo, R. T. D'Aquila, J. T. Kurnick, and B. D Walker. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus I envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261.
29. Jäger, E., Y.-T. Chen, J. W. Drijfhout, J. Karbach, M. Ringhoffer, D. Jäger, M. Arand, H. Wada, Y. Noguchi, E. Stockert, et al. 1998. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. Exp. Med. 187:265.